GILEAD SCIENCES INC Insider Trading for April 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for April 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Gift | G | 0.00 | 338 | 0 | 12,778 | 13.1 K to 12.8 K (-2.58 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Option Exercise | M | 16.40 | 90,000 | 1,475,550 | 340,000 | |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 68.01 | 7,703 | 523,853 | 119,302 | 127 K to 119.3 K (-6.07 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 67.23 | 50,307 | 3,382,119 | 127,005 | 177.3 K to 127 K (-28.37 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Sell | S | 66.47 | 31,990 | 2,126,510 | 177,312 | 209.3 K to 177.3 K (-15.28 %) |
| Apr 16 2014 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Buy | M | 16.40 | 90,000 | 1,475,550 | 209,302 | 119.3 K to 209.3 K (+75.44 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 26.99 | 8,824 | 238,160 | 91,176 | |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 21.58 | 7,904 | 170,529 | 0 | |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 70.20 | 6,328 | 444,205 | 28,562 | 34.9 K to 28.6 K (-18.14 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 70.73 | 10,400 | 735,577 | 34,890 | 45.3 K to 34.9 K (-22.96 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 26.99 | 8,824 | 238,160 | 45,290 | 36.5 K to 45.3 K (+24.20 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 21.58 | 7,904 | 170,529 | 36,466 | 28.6 K to 36.5 K (+27.67 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 36,820 | 0 | 63,600 | 26.8 K to 63.6 K (+137.49 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 36,820 | 0 | 49,832 | 86.7 K to 49.8 K (-42.49 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 5,000 | 71,688 | 86,000 | |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 70.99 | 2,100 | 149,071 | 39,542 | 41.6 K to 39.5 K (-5.04 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 70.24 | 2,900 | 203,684 | 41,642 | 44.5 K to 41.6 K (-6.51 %) |
| Apr 10 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 5,000 | 71,688 | 44,542 | 39.5 K to 44.5 K (+12.64 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 55,000 | |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 73.09 | 5,000 | 365,450 | 13,116 | 18.1 K to 13.1 K (-27.60 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 18,116 | 13.1 K to 18.1 K (+38.12 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 21.58 | 11,000 | 237,325 | 16,367 | |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 73.17 | 2,000 | 146,334 | 132,694 | 134.7 K to 132.7 K (-1.48 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 73.77 | 200 | 14,754 | 134,694 | 134.9 K to 134.7 K (-0.15 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 73.20 | 10,800 | 790,551 | 134,894 | 145.7 K to 134.9 K (-7.41 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 21.58 | 11,000 | 237,325 | 145,694 | 134.7 K to 145.7 K (+8.17 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 1,125,008 | |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 73.47 | 68,910 | 5,062,652 | 4,429,387 | 4.5 M to 4.4 M (-1.53 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 73.06 | 71,715 | 5,239,376 | 4,498,297 | 4.6 M to 4.5 M (-1.57 %) |
| Apr 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |